Torrent to pay $324m for Elder's branded formulations business, beating fancier rivals
This article was originally published in Scrip
Executive Summary
Torrent Pharmaceuticals has acquired the branded domestic formulations business of the Indian firm, Elder Pharmaceuticals, for INR20bn ($323.5m), ending months of speculation of an imminent deal and apparently pipping fancier suitors, such as Sanofi, along the way.